Opioid mu, delta and kappa receptor-induced activation of phospholipase C-3 and inhibition of adenylyl cyclase is mediated by G and G i 2 in smooth muscle
Clinical trials leading to FDA approval demonstrated significant visceral fat reduction in patients with excess abdominal fat accumulation, validating what clinicians now see consistently in practice
For hair and skin, the evidence includes topical skin trials, wound studies, mouse hair-follicle data, and related copper-peptide hair follicle models rather than large, modern randomized trials for hair loss [2], [3], [6], [13]
Reconstitution, sourcing, and COA questions welcome
(Drug Des Devel Ther, 2020) specifically compared bioavailability between oral and subcutaneous BPC-157 in healthy volunteers
That then tends to become a self-reinforcing cycle so that the person gains weight, which worsens the problem, and they gain more weight, which further worsens the problem